You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 807 A multicenter open-label phase I/lb study of SO-C101 as monotherapy and in combination with pembrolizumab in patients with selected advanced/metastatic solid tumors

Article metrics

Article menu

Download PDFPDF

Late-breaking abstracts
Clinical trials in-progress
807 A multicenter open-label phase I/lb study of SO-C101 as monotherapy and in combination with pembrolizumab in patients with selected advanced/metastatic solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020196013
Dec 202045012
Jan 20211404
Feb 20214403
Mar 202152011
Apr 202136012
May 2021407
Jun 2021007
Jul 2021005
Aug 2021004
Sep 20210014
Oct 202138028
Nov 202140015
Dec 20213605
Jan 20227207
Feb 202238010
Mar 20227406
Apr 20225807
May 202248011
Jun 202258013
Jul 20226007
Aug 20223803
Sep 20223404
Oct 20224202
Nov 20222401
Dec 20223001
Jan 20231801
Feb 20234006
Mar 20234202
Apr 20231804
May 20231805
Jun 20231803
Jul 20231403
Aug 20232202
Sep 20231000
Oct 20232803
Nov 20232003
Dec 20232601
Jan 2024801
Feb 20242600
Mar 20242802
Apr 20241609
May 20243601
Jun 20243601
Jul 20242002
Aug 20241903
Sep 20243204
Oct 20243305
Nov 20242206
Dec 20241406
Jan 202528013
Feb 20251208
Mar 2025005
Apr 2025003
May 2025002
Jun 2025006
Total16850322